OMEN Pharma

Experts gathered at the 73rd IPC in Hyderabad emphasized the evolving landscape of excipient quality and regulatory standards, attributing this shift to technological advancements, global alignment efforts, and a strong commitment to patient safety and product efficacy. During discussions themed around “Excipients-Pharma Partner in Delivering Quality Medicines,” panelists highlighted the critical role of excipients in … Read more

The Delhi High Court has taken up petitions calling for a ban on the online sale of medicines, moving forward with a hearing on the issue after the Central government revealed it has yet to establish regulations for e-pharmacies. This development came to light through statements made by the South Chemists & Distributors Association (SCDA), … Read more

Nathealth-Healthcare Federation of India has put forward a compelling case for substantial reforms aimed at revolutionizing India’s healthcare landscape in the upcoming Union Budget 2024-25. Advocating for a comprehensive overhaul, Nathealth’s recommendations span critical areas such as healthcare infrastructure expansion, separate policies for medical devices, services, and diagnostics, and according national priority status to healthcare. … Read more

Roche has just achieved a significant milestone with its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution receiving the CE Mark. This means the device is now approved for people over 18 with type 1 and type 2 diabetes who are on flexible insulin therapy. Matt Sause, CEO of Roche Diagnostics, highlighted the challenges faced by … Read more

Pharmacy Students Gear Up for Global Regulatory Challenges In a bid to navigate the intricate landscape of global pharmaceutical regulations, pharmacy students are increasingly focusing on qualification, training, and upskilling strategies. According to insights gathered by Pharmabiz from pharmacy students, the path to career advancement now hinges on mastering technology, regulations, and data analytics. These … Read more

First Case Under Bharatiya Nyaya Sanhita, 2023 Targets Illegal Drug Manufacturing in Telangana In a significant crackdown on counterfeit drug manufacturing, Telangana’s Pet Basheerabad Police Station has registered the first case under the Bharatiya Nyaya Sanhita, 2023 against an illegal drug manufacturer. The offender, operating clandestinely in Medchal-Malkajgiri district, was found producing counterfeit versions of … Read more

In response to recent closures affecting 36% of inspected drug manufacturing units nationwide due to non-compliance with Revised Schedule M standards, the Pondicherry Drug Manufacturers Association (PDMA) is set to host a seminar aimed at educating industry stakeholders on the updated Good Manufacturing Practices (GMP). Scheduled for July 13 in the union territory, the seminar … Read more

Budget 2024-25: Pharma, Healthcare Leaders Call for Strategic Investments and Policy Reforms As India gears up for the Union Budget 2024-25, leaders from the pharmaceutical and healthcare sectors are advocating for strategic investments, policy reforms, and incentives to bolster innovation and accessibility in healthcare. The Indian Pharmaceutical Alliance (IP Alliance), Metropolis Healthcare, Alyve Health, and … Read more

Indian pharmaceutical companies regularly leverage events like the Indian Pharmaceutical Congress (IPC) to showcase their latest advancements in drug development, technology integration, and adherence to global quality standards. Industry leaders emphasize that IPC serves as a crucial platform for demonstrating India’s capabilities in innovation and its significant contributions to global healthcare through affordable medicines and … Read more